Inorganic Nanomaterials versus Polymer-Based Nanoparticles for Overcoming Neurodegeneration

Inorganic Nanomaterials versus Polymer-Based Nanoparticles for Overcoming Neurodegeneration

Neurodegenerative disorders (NDs) affect a great number of people worldwide and also have a significant socio-economic impact on the aging population. In this context, nanomedicine applied to neurological disorders provides several biotechnological strategies and nanoformulations that improve life e...

Full description

Bibliographic Details
Main Authors:	Simona Martano, Valeria De Matteis, Mariafrancesca Cascione, Rosaria Rinaldi
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	Nanomaterials
Subjects:	neurodegeneration neuroprotection nanocarriers blood–brain barrier brain-targeting drug-delivery
Online Access:	https://www.mdpi.com/2079-4991/12/14/2337

Similar Items

Magnesium and the Brain: A Focus on Neuroinflammation and Neurodegeneration
by: Jeanette A. M. Maier, et al.
Published: (2022-12-01)

How Precise are Nanomedicines in Overcoming the Blood–Brain Barrier? A Comprehensive Review of the Literature
by: Mohapatra P, et al.
Published: (2024-03-01)

Overcoming the Blood–Brain Barrier. Challenges and Tricks for CNS Drug Delivery
by: Luca Anna Bors, et al.
Published: (2019-02-01)

Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer’s Disease Proteinopathy: Possible Therapeutic Role of Curcumin
by: Ryszard Pluta, et al.
Published: (2022-01-01)

Current Update on Transcellular Brain Drug Delivery
by: Bhakti Pawar, et al.
Published: (2022-12-01)

Theoretical and applied concepts of nanocarriers for the treatment of Parkinson's diseases
by: Anjali Bhosale, et al.
Published: (2023-01-01)

Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood–Brain Barrier
by: Julia V. Georgieva, et al.
Published: (2014-11-01)

Role of Hydroxytyrosol and Oleuropein in the Prevention of Aging and Related Disorders: Focus on Neurodegeneration, Skeletal Muscle Dysfunction and Gut Microbiota
by: Laura Micheli, et al.
Published: (2023-04-01)

Nanoparticles for Diagnosis and Target Therapy in Pediatric Brain Cancers
by: Clara Guido, et al.
Published: (2022-01-01)

Clay Nanotubes Loaded with Diazepam or Xylazine Permeate the Brain through Intranasal Administration in Mice
by: Yaswanthi Yanamadala, et al.
Published: (2023-06-01)

Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors
by: Giovanna Calabrese, et al.
Published: (2021-10-01)

Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood–Brain Barrier by Using Different Transport Mechanisms
by: Jisu Song, et al.
Published: (2021-09-01)

Emerging Anesthetic Nanomedicines: Current State and Challenges
by: Zhang S, et al.
Published: (2023-07-01)

Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments
by: Edoardo Scarpa, et al.
Published: (2023-09-01)

Drug Delivery to the Brain: Recent Advances and Unmet Challenges
by: Sukanya Bhunia, et al.
Published: (2023-11-01)

Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia
by: Marzena Ułamek-Kozioł, et al.
Published: (2020-01-01)

Multifunctional Nanopolymers for Blood–Brain Barrier Delivery and Inhibition of Glioblastoma Growth through EGFR/EGFRvIII, c-Myc, and PD-1
by: Rameshwar Patil, et al.
Published: (2021-10-01)

Editorial: Vascular and perivascular contributions to neurodegeneration
by: Giuseppe Barisano, et al.
Published: (2023-09-01)

Natural Polysaccharide Carriers in Brain Delivery: Challenge and Perspective
by: Manuela Curcio, et al.
Published: (2020-12-01)

Liposomes for the Treatment of Brain Cancer—A Review
by: Richu Raju, et al.
Published: (2023-07-01)

Polysaccharide-Based Nanogels to Overcome Mucus, Skin, Cornea, and Blood-Brain Barriers: A Review
by: Ju Wang, et al.
Published: (2023-10-01)

“Let Food Be Thy Medicine”: Gluten and Potential Role in Neurodegeneration
by: Aaron Lerner, et al.
Published: (2021-03-01)

Pantothenate kinase-associated neurodegeneration: Clinical aspects, diagnosis and treatments
by: Saeed Razmeh, et al.
Published: (2018-04-01)

An Angiopep2-PAPTP Construct Overcomes the Blood-Brain Barrier. New Perspectives against Brain Tumors
by: Sofia Parrasia, et al.
Published: (2021-02-01)

Peripheral extracellular vesicles in neurodegeneration: pathogenic influencers and therapeutic vehicles
by: Xixi Liu, et al.
Published: (2024-04-01)

A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients
by: Mohammad Rohani, et al.
Published: (2018-02-01)

Neuroprotective Effects of Allicin on Neurological Scores, Blood Brain Barrier Permeability and Brain Edema Following Severe Traumatic Brain Injury in Male Rats: A Behavioral, Biochemical and Histological Study
by: Seyed Reza Seyedin, et al.
Published: (2023-01-01)

Neuroprotective Effects of Allicin on Neurological Scores, Blood Brain Barrier Permeability and Brain Edema Following Severe Traumatic Brain Injury in Male Rats: A Behavioral, Biochemical and Histological Study
by: Seyed Reza Seyedin, et al.
Published: (2023-01-01)

Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: screening based on pharmacological and physiological properties
by: Jignesh D. Pandya, et al.
Published: (2024-02-01)

Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System
by: Tyler P. Crowe, et al.
Published: (2022-03-01)

Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date
by: Bwalya Angel Witika, et al.
Published: (2022-04-01)

Overcoming the Blood-Brain Barrier: Functionalised Chitosan Nanocarriers
by: Anna E. Caprifico, et al.
Published: (2020-10-01)

Exploring Sphingolipid Implications in Neurodegeneration
by: Alice V. Alessenko, et al.
Published: (2020-05-01)

Co-Culture Models: Key Players in In Vitro Neurotoxicity, Neurodegeneration and BBB Modeling Studies
by: Ana Rita Monteiro, et al.
Published: (2024-03-01)

Alzheimer’s Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology
by: Mugdha Agarwal, et al.
Published: (2020-12-01)

Neuroprotective Effects of Resveratrol in Ischemic Brain Injury
by: Noelia D. Machado, et al.
Published: (2021-09-01)

Blood–Brain Barrier Disruption and Its Involvement in Neurodevelopmental and Neurodegenerative Disorders
by: Ana Aragón-González, et al.
Published: (2022-12-01)

Nucleic acid delivery by ionizable nanocarriers for brain disease treatment
by: Ruru Xiong, et al.
Published: (2023-03-01)

Nanocarriers for Delivery of Oligonucleotides to the CNS
by: David Male, et al.
Published: (2022-01-01)

The Role of Natural Compounds and their Nanocarriers in the Treatment of CNS Inflammation
by: Bikram Khadka, et al.
Published: (2020-10-01)